2021
DOI: 10.1016/j.ejps.2020.105684
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics of bilirubin-10-sulfonate and biliverdin in the rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…The low p K a * value of bilirubin-10-sulfonate seems to be due to its high polarity caused by the sulfonate anion, probably resulting in a p K a * value that is close to that of short chain carboxylic acids 19 . The difference in p K a * values of bilirubin-10-sulfonate and UCB may explain the different biological behavior of bilirubin-10-sulfonate with surprisingly strong intraperitoneal absorption and intravascular retention after intravenous or intraperitoneal administration, and little absorption after intraduodenal administration 29 .…”
Section: Discussionmentioning
confidence: 99%
“…The low p K a * value of bilirubin-10-sulfonate seems to be due to its high polarity caused by the sulfonate anion, probably resulting in a p K a * value that is close to that of short chain carboxylic acids 19 . The difference in p K a * values of bilirubin-10-sulfonate and UCB may explain the different biological behavior of bilirubin-10-sulfonate with surprisingly strong intraperitoneal absorption and intravascular retention after intravenous or intraperitoneal administration, and little absorption after intraduodenal administration 29 .…”
Section: Discussionmentioning
confidence: 99%
“…The preparations were intraduodenally (i.d.) administered to avoid damage from acidic environment in stomach 20 , 21 . In brief, the rats were anesthetized with 0.3 g/kg chloral hydrate via intraperitoneal injection; following remove of the abdominal hair, a 1-cm incision was made below xiphoid process; a suture was tied gently ∼3 cm distal to the pylorus around the duodenum, preventing the dose from flowing back into the stomach; each preparation at a dose equivalent to 10 mg/kg of PTX was injected 8 cm distal to the pylorus; subsequently, the injection site was sealed by a drop of super glue (Compont Medical Equipment Co., Ltd., Beijing, China), while the suture was removed 3 min later; the abdomen was carefully sutured; at predetermined intervals, 500 μL blood was collected from the eye socket.…”
Section: Methodsmentioning
confidence: 99%